Application of balloon pulmonary push device in stereotactic radiotherapy

Abstract

The invention discloses an application of a balloon pulmonary push device in stereotactic radiotherapy. The invention further provides a use method of a balloon pulmonary push device in stereotactic radiotherapy. The method includes the following steps that S1 the conduit of the balloon pulmonary push device is sent to a specified position in a patient's thoracic cavity by means of a pleura cavity puncture needle; S2 10-20ml of aseptic normal saline is injected into the liquid injection inlet of the balloon pulmonary push device, the balloon of the balloon pulmonary push device is fully filled to push the lung tissues to the mediastinum direction to be away from chest wall; S3 the position of the balloon pulmonary push device is fixed; and S4 the patient is subjected to radiation treatment, and the balloon pulmonary push device can be removed after the radiation treatment is completed. According to the invention, the stereotactic radiotherapy can protect the chest wall tissues, particularly, ribs and rib nerves in the early stage of a lung cancer patient having a tumor close to the pleura, and can prevent the pains caused by radiotherapy complication complications while curing early stage lung cancer.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to the application of a balloon lung pusher in stereotactic radiotherapy. Background technique [0002] With the continuous progress in the field of medical technology and the improvement of people's attention to health, the diagnosis rate of early cancer has been greatly improved. Studies at home and abroad have shown that early lung cancer can obtain the same therapeutic effect as surgery with hyperfractionated stereotactic radiotherapy. . In the current lung cancer patients, the distance between the tumor and the chest wall in a considerable number of patients is very short. When undergoing hyperfractionated stereotactic radiotherapy, since the tumor is located close to the chest wall, necrosis of the chest wall and ribs will occur after radiotherapy, which hinders some lung cancers. The implementation of stereotactic radiotherapy for patients, such patients will receive surgic...

AI Technical Summary

Problems solved by technology

In the current lung cancer patients, the distance between the tumor and the chest wall in a considerable number of patients is very short. When performing hypofractionated stereotactic radiotherapy, since the tumor is located close to the chest wall, necrosis of the chest wall and ribs will occur after radiotherapy, which hinders some lung cancers. The implementation of stereotactic radiotherapy for patients, such patients will receive surgical treatment, causing patients to suffer double injuries and pain